Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

The Food and Drug Administration announced sweeping changes to its COVID-19 vaccine policy Tuesday, signaling a major ...

No, this is not true. Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for certain ...

The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other groups at high risk for severe illness.

GENEVA (AP) — World Health Organization member countries on Tuesday approved an agreement to better prevent, prepare for and respond to future pandemics in the wake of the devastation wrought by the ...

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

US negotiators stepped away from the process after President Donald Trump initiated a formal withdrawal from the WHO upon ...

The treaty’s formal approval at the annual meeting of the World Health Organization (WHO) came after some late-breaking ...

The vaccine, Nuvaxovid, is the third coronavirus shot to gain full approval, joining vaccines from Pfizer and Moderna. It has ...

After nearly 80 years of striving to improve human lives and health the UN health agency is fighting for its own after Trump ...

The FDA's full approval of Nuvaxovid triggered a $175 million milestone payment to Novavax from Sanofi, related to their ...